Comanche

Developer of RNA therapeutics to treat preeclampsia

placeConcord, Massachusetts, United States calendar_todayFounded 2020 groups17 employees language comanchebiopharma.com

Social engagement

Social engagement: 5.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Google Ventures, F-Prime Capital, Lilly Asia Ventures, New Enterprise Associates.

Investor typeCountShare
Venture capital571%
Other / undisclosed229%

Recent activity

21 May 2026
Event
From Patients to Pioneers: Three Women, Three Paths after Preeclampsia
Coming soon